Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Switching from natalizumab to fingolimod: A randomized, placebo-controlled study in RRMS.
"Undiagnosing" multiple sclerosis: The challenge of misdiagnosis in MS.
Galectin-1 for neuroprotection?
Effect of met-enkephalin on chromosomal aberrations in the lymphocytes of the peripheral blood of patients with multiple sclerosis.
VLA-4 blockade promotes differential routes into human CNS involving PSGL-1 rolling of T cells and MCAM-adhesion of TH17 cells.
Epstein-Barr virus-specific adoptive immunotherapy for progressive multiple sclerosis.
Administration of monthly-pulse cyclophosphamide in multiple sclerosis patients. Effects of long-term treatment on immunologic parameters.
Amiloride Clinical Trial In Optic Neuritis (ACTION)
Glatiramer acetate treatment effects on gene expression in monocytes of multiple sclerosis patients.
Impact of glatiramer acetate on paraclinical markers of neuroprotection in multiple sclerosis: A prospective observational clinical trial.
HERV-W envelope protein inhibits oligodendroglial precursor cell differentiation.
Safety, Tolerability and Efficacy of Monthly Long-acting IM Injection of 80 mg GA Depot in Subjects With RRMS
The epidemiology of multiple sclerosis in Latin America and the Caribbean: a systematic review.
Altered microRNA expression in B lymphocytes in multiple sclerosis: Towards a better understanding of treatment effects.
Laquinimod prevents inflammation-induced synaptic alterations occurring in experimental autoimmune encephalomyelitis.
Development of the Brief Inventory of Perceived Stress.
Assessment of sphingosine-1-phosphate receptor expression and associated intracellular signaling cascades in primary cells of the human central nervous system.
Multiple sclerosis susceptibility genes: associations with relapse severity and recovery.
Predictors of quality of life among multiple sclerosis patients: a comprehensive analysis.
Human autoimmunity after lymphocyte depletion is caused by homeostatic T-cell proliferation.
The Impact of Lesion In-Painting and Registration Methods on Voxel-Based Morphometry in Detecting Regional Cerebral Gray Matter Atrophy in Multiple Sclerosis.
Pilot trial of low-dose naltrexone and quality of life in multiple sclerosis.
Editorial for JNV issue on PML.
Secret talk between adipose tissue and central nervous system via secreted factors-an emerging frontier in the neurodegenerative research.
Recommendations for the clinical use of motor evoked potentials in multiple sclerosis.
Pages
« first
‹ previous
…
100
101
102
103
104
105
106
107
108
…
next ›
last »